ClinicalTrials.gov
public full text
Public Domain
The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism
we propose that bromocriptine may be an alternative treatment of primary aldosteronism, both APA and BAH.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prognosis of Primary Aldosteronism: A Prospective Cohort Study#414403
- Spironolactone Safety in Dialysis Patients#1162356
- Statin Combined with Amlodipine Treats Primary Aldosteronism#907653
- Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?#802927
- RAS Blockade at Bedtime Versus on Awakening for Aldosterone Breakthrough#832061
Record · ID 979774
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive